Corneal stromal stem cells restore transparency after N


Journal

Stem cells translational medicine
ISSN: 2157-6580
Titre abrégé: Stem Cells Transl Med
Pays: England
ID NLM: 101578022

Informations de publication

Date de publication:
08 2020
Historique:
received: 17 09 2019
revised: 23 03 2020
accepted: 27 03 2020
pubmed: 8 5 2020
medline: 27 7 2021
entrez: 8 5 2020
Statut: ppublish

Résumé

Corneal scarring associated with various corneal conditions is a leading cause of blindness worldwide. The present study aimed to test the hypothesis that corneal stromal stem cells have a therapeutic effect and are able to restore the extracellular matrix organization and corneal transparency in vivo. We first developed a mouse model of corneal stromal scar induced by liquid nitrogen (N

Identifiants

pubmed: 32379938
doi: 10.1002/sctm.19-0306
pmc: PMC7381812
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

917-935

Informations de copyright

© 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.

Références

Invest Ophthalmol Vis Sci. 2005 May;46(5):1653-8
pubmed: 15851565
Int Rev Cytol. 1980;63:263-322
pubmed: 395131
Stem Cells. 2009 Jul;27(7):1635-42
pubmed: 19544455
Stem Cells Dev. 2010 Nov;19(11):1651-62
pubmed: 20629538
Acta Ophthalmol. 2017 Jun;95(4):e297-e306
pubmed: 28133954
Invest Ophthalmol Vis Sci. 2005 May;46(5):1620-5
pubmed: 15851560
Biomed Res Int. 2015;2015:257927
pubmed: 26491663
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4237-46
pubmed: 14507867
J Clin Invest. 1987 Feb;79(2):319-26
pubmed: 3543052
Exp Eye Res. 2014 Mar;120:71-81
pubmed: 24440595
J Exp Med. 1975 Aug 1;142(2):346-60
pubmed: 167095
Am J Ophthalmol. 2003 Sep;136(3):530-6
pubmed: 12967809
Prog Retin Eye Res. 1999 May;18(3):293-309
pubmed: 10192515
Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):8947-52
pubmed: 19447928
Invest Ophthalmol Vis Sci. 1998 Feb;39(2):276-83
pubmed: 9477983
Dev Biol. 2005 Dec 1;288(1):284-93
pubmed: 16263107
Acta Biomater. 2017 Aug;58:291-301
pubmed: 28559158
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4044-4053
pubmed: 30098200
Sci Transl Med. 2014 Dec 10;6(266):266ra172
pubmed: 25504883
Exp Eye Res. 2014 Dec;129:151-60
pubmed: 25281830
Tissue Eng Part C Methods. 2015 Dec 28;22(2):165-172
pubmed: 26585450
Curr Eye Res. 2015 May;40(5):526-34
pubmed: 25251769
Mol Vis. 2011 Feb 01;17:341-54
pubmed: 21297898
Stem Cells. 2017 May;35(5):1176-1188
pubmed: 28220575
Cornea. 2005 Nov;24(8 Suppl):S2-S11
pubmed: 16227819
Tissue Eng Part A. 2013 Sep;19(17-18):2063-75
pubmed: 23557404
Int J Biochem Cell Biol. 2006;38(10):1625-31
pubmed: 16675284
Sci Rep. 2017 Oct 19;7(1):13584
pubmed: 29051516
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19879-84
pubmed: 18077420
Int Ophthalmol. 2018 Oct;38(5):2257-2266
pubmed: 28852910
J Biomed Opt. 2015 Jan;20(1):016001
pubmed: 25554970
Ophthalmic Physiol Opt. 2005 May;25(3):254-60
pubmed: 15854073
Exp Eye Res. 2010 Sep;91(3):326-35
pubmed: 20599432
Appl Opt. 2004 May 10;43(14):2874-83
pubmed: 15143811
J Tissue Eng Regen Med. 2018 Jan;12(1):59-69
pubmed: 27863068
Cell Rep. 2014 Nov 20;9(4):1191-201
pubmed: 25456121
Biomaterials. 2012 Feb;33(5):1343-52
pubmed: 22078813
Exp Eye Res. 2016 Apr;145:289-296
pubmed: 26836248
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5038-45
pubmed: 17962455
Arch Ophthalmol. 1998 Nov;116(11):1470-4
pubmed: 9823348
Exp Eye Res. 1997 Oct;65(4):575-89
pubmed: 9464190
PLoS One. 2017 Mar 3;12(3):e0171712
pubmed: 28257425
Stem Cells Transl Med. 2018 Jun;7(6):487-494
pubmed: 29654654
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4200-8
pubmed: 16249499
Ocul Surf. 2016 Apr;14(2):113-20
pubmed: 26804252
Prog Retin Eye Res. 1999 May;18(3):311-56
pubmed: 10192516
Exp Eye Res. 1996 Apr;62(4):325-7
pubmed: 8795451
Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319
pubmed: 9493273
Stem Cells. 2005 Oct;23(9):1266-75
pubmed: 16051989
Am J Pathol. 1987 Apr;127(1):140-8
pubmed: 3565534
PLoS One. 2017 Nov 17;12(11):e0188398
pubmed: 29149196
Ophthalmology. 1982 Jun;89(6):531-90
pubmed: 7122038
Stem Cells Transl Med. 2020 Aug;9(8):917-935
pubmed: 32379938
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):4990-4996
pubmed: 28979996
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4126-31
pubmed: 15505065
Prog Retin Eye Res. 2015 Nov;49:17-45
pubmed: 26197361
Cornea. 2016 Dec;35(12):1621-1630
pubmed: 27560027
Ophthalmology. 1995 Dec;102(12):2046-9
pubmed: 9098316
J Anat. 2005 Nov;207(5):447-59
pubmed: 16313387
Trans Am Ophthalmol Soc. 2003;101:293-333
pubmed: 14971584
J Cataract Refract Surg. 2008 May;34(5):796-801
pubmed: 18471635

Auteurs

Djida Ghoubay (D)

Institut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France.
Centre Hospitalier National d'Ophtalmologie des 15-20, DHU Sight Restore, INSERM-DHOS CIC, Paris, France.

Marie Borderie (M)

Centre Hospitalier National d'Ophtalmologie des 15-20, DHU Sight Restore, INSERM-DHOS CIC, Paris, France.

Kate Grieve (K)

Institut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France.

Raphaël Martos (R)

Laboratoire de Recherche Vasculaire Translationnelle, INSERM U1148, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Romain Bocheux (R)

Laboratoire d'Optique et Biosciences (LOB) École polytechnique, CNRS UMR 7645, INSERM U 1182, Palaiseau cedex, France.

Thu-Mai Nguyen (TM)

Institut Langevin Ondes et images CNRS UMR 7587, INSERM U979 Physiques des ondes pour la médecine, ESPCI, Paris, France.

Patrice Callard (P)

Sorbonne Université, APHP, Hôpital Pitié Salpêtrière, Paris, France.

Alain Chédotal (A)

Institut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France.

Vincent M Borderie (VM)

Institut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France.
Centre Hospitalier National d'Ophtalmologie des 15-20, DHU Sight Restore, INSERM-DHOS CIC, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH